Anebulo Pharmaceuticals (ANEB) Return on Assets (2021 - 2025)
Anebulo Pharmaceuticals (ANEB) posted quarterly Return on Assets of 0.01% for Q4 2025, little changed year-over-year from 0.01% in Q4 2024, and down 12.15% quarter-over-quarter from 0.01% in Q3 2025.
Anebulo Pharmaceuticals (ANEB) Return on Assets (2021 - 2025) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Return on Assets for 5 consecutive years, with 0.01% the latest figure, recorded in Q4 2025.
- In Q4 2025, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets slipped to 0.01% in Q4 2025 per ANEB's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q3 2021 and bottomed at 0.03% in Q3 2024.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2022.
- Annual changes were most pronounced in 2022 — Return on Assets decreased 1 bps — and 2025, when it rose 2 bps.
- Anebulo Pharmaceuticals' Return on Assets stood at 0.0% in 2021, then sank by 128 bps to 0.01% in 2022, then slumped by 111 bps to 0.02% in 2023, then jumped by 53 bps to 0.01% in 2024, then retreated by 12 bps to 0.01% in 2025.
- Business Quant data shows ANEB's Return on Assets at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 0.00% |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.03% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |